Certolizumab Pegol Promising for Plaque Psoriasis in Phase 3 Trial
Rheumatology Drug Updates: Giant Cell Arteritis Relapse Possible if Tocilizumab Discontinued; Plus Updates on Rituximab, Etanercept
FDA Update on Rituximab & Etanercept; Plus New ACP Gout Guideline
Reinitiating TNF Blockers after Tuberculosis Treatment
Big Pharma vs. Big Pharma in Court Battles over Biosimilar Drugs
FDA Approves Etanercept-szzs Biosimilar
U.S. FDA Approves Biosimilar to Etanercept
Tildrakizumab Promising for Plaque Psoriasis; FDA Approves Adalimumab to Treat Panuveitis